Selling Stockholder Registers Resale of 255,103 Shares from December 2025 Private Placement
ALLR sits 80% above its 52-week low of $0.769.
Summary
An institutional investor, 3i, LP, is registering 255,103 shares for resale, which were acquired in a December 2025 private placement, potentially adding selling pressure to the stock.
Key Events · Financing and Capital Events · ALLR
-
Resale of Shares Registered
Selling stockholder 3i, LP has registered 255,103 shares of common stock for resale. The company will not receive any proceeds from these sales.
-
Shares from December 2025 Private Placement
The shares being registered for resale were originally issued to 3i, LP in a private placement completed on December 23, 2025, at a price of $0.98 per share.
-
Potential Market Overhang
The potential sale of these shares, valued at approximately $357,144 based on the last reported price, represents about 1.68% of the company's current market capitalization, which could exert downward pressure on the stock.
Analysis · ALLR · Life Sciences
This 424B3 prospectus details the registration for resale of 255,103 common shares by selling stockholder 3i, LP. These shares were originally acquired in a private placement on December 23, 2025, at $0.98 per share. While the company will not receive any proceeds from this resale, the potential sale of shares representing approximately 1.68% of the current market capitalization by an institutional investor could create an overhang on the stock, especially for a company of this size. This follows the S-3/A filing on April 24, 2026, which likely initiated the shelf registration process for these shares.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALLR was trading at $1.38 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.2M. The 52-week trading range was $0.77 to $2.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.